The researchers from the Imperial College London have analysed 20 pharmacies that were accessible for ordering from by UK citizens online. The study conducted by Imperial College London is one of the few that take a closer look at online availability of antibiotics and the potential impact it could have on the public health. Antibiotics
Regulatory Associate – J27481Scotland, >UK
Statistics Manager – J27496London East, London, Hampshire, Buckinghamshire, Berkshire, >UK
Business Intelligence Analyst (15 Month Fixed Term Contract) – J26844Middlesex, London, Buckinghamshire, Berkshire, >UK
Brand Manager – 3 Months Contract – J27491Germany, Europe
Senior Sterilisation Scientist Location: Leeds Employment Type: 6-12 Month Initial Contract Salary: £comp Clinical Professionals have recently registered a new
Europe's Leading Life Science Staffing Business
Clinical Professionals is Europe's leading pharmaceutical research and development recruitment company, with a focus on job placement in the scientific, pharmacology, clinical development and post approval services. We are dedicated to staffing in the Pharmaceutical, Biotechnology, Devices and CRO industries throughout Europe. Our client portfolio includes global leaders in pharmaceutical development and clinical research, whilst our expertise encompasses a wide remit of life science job sectors, including dedicated teams within clinical research, drug safety and pharmacovigilance jobs, medical communications jobs, QA/QC jobs, regulatory affairs jobs and medical affairs jobs. Clinical Professionals always provides candidates and clients with services of the highest ethical standards.
As Europe's leading life science staffing agency, Clinical Professionals offer a unique array of services which include “Pipeline Watch” – our advisory consultation programme which is free for candidates, as well as our “Talent Tracker” service – a tracking database that lets us identify as well as track candidates across Europe that matches clients staffing needs in the future.
Clinical Professionals have recently launched their new Graduate Training Academy which identifies, fully funds and trains the most talented Life Sciences University Graduates within the UK and places them into CTA and CRA jobs.
Clinical Professionals provide the candidates and client alike with the consultative approach of a specialist staffing organisation combined with the Pan-European coverage of an industry leading supplier. We provide our clients and candidates with unrivalled specialist understanding, knowledge and experience in the staffing needs of the life sciences industry.
Specialist Pharmaceutical Jobs Sectors
Clinical Professionals provide jobs within the Life Science community, being the most effective European online pharmaceutical jobs and careers management company in the pharmaceutical, clinical research, medical device, biotech and health care industries. Each of our consultants are strategically aligned to one of these specialist sectors which means that job seekers are assured they are working with consultants who have in-depth role and job knowledge and are experts at placing individuals in their chosen pharmaceutical job sector. Clinical Professional recruits for various clinical jobs including pharmacovigilance, regulatory affairs, Biometrics, Health Economic, medical communication, Scientific and Medical Information.
Contact us today to find out how we can progress your career to the next level
The pharmaceutical company recently unveiled late stage data that shows their experimental two-drug regimen of its dolutegravir and Janssen Science’s rilpivirine was comparable in efficacy to three- or four-drug antiretroviral regimens in virologically suppressed patients. The dolutegravir/rilpivirine combination treatment achieved non-inferior viral suppression at 48 weeks compared with a three- or four-drug regimen in both
Bayer has put the blood-thinning drug through its paces in the Phase 3 trial to determine if it could help patients at risk from heart attacks and strokes due to a type of artery disease. The trial was scheduled to end by 2018, however it has proven to be so successful that Bayer could end